Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Centers of Excellence for Translational Research (CETR)

In 2014, NIAID established the Centers of Excellence for Translational Research program to advance discovery, preclinical development, production, licensure and/or use of new or improved medical countermeasures (therapeutics, immunotherapeutics, vaccines, vaccine technologies, and medical diagnostics) or related technologies for emerging and re-emerging infectious diseases. Each multi-project Center is organized around a specific theme that addresses development of a targeted medical countermeasure or technology, and related regulatory barriers. Supported translational activities will range from very early discovery-based efforts to late-stage preclinical development.

The CETR program builds on work of previous NIAID-supported research and development programs, including the Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) program and is intended to complement and enhance ongoing translational and product development activities.


Columbia University
PI: Ian Lipkin
Center for Research in Diagnostics and Discovery

Harvard University (Medical School)
PI: Dennis Kasper
Title: Innovative Platforms for Antimicrobial Therapy and Vaccine Development

Harvard University (Medical School)
PI: Megan Murray
Title: Integrated Discovery and Development of Innovative Tb Diagnostics

Harvard University (Medical School)
PI: Sean Whelan
Title: Small Molecule Inhibitors of Enveloped Virus Entry

Mount Sinai School of Medicine
PI: Christopher Basler
Title: Therapeutics Targeting Filoviral interferon-antagonist and replication functions

Rutgers - New Jersey Medical School
PI: David Perlin
Title: Center to Develop Therapeutic Countermeasures to High-Threat Bacterial Agents

Scripps Research Institute
PI: Erica Saphire
Title: Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers

Stanford University
PI: Jeffrey Glenn
Title: Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic

University of Alabama at Birmingham
PI: Richard Whitley
Title: Antiviral Drug Discovery and Development Center

University of Maryland Baltimore
PI: Myron Levine
Title: Immunoprophylactic Strategies to Control Emerging Enteric Infections

University of North Carolina
PI: Jenny Ting
Title: Novel Nanoparticle Platform for the Delivery of Vaccines and Adjuvants

University of Texas Medical Branch Galveston
PI: Thomas Geisbert
Title: Advancement of Treatments for Ebola and Marburg Virus Infections

University of Wisconsin
PI: David Andes
Title: Antimicrobial Drug Discovery from Coevolved Symbiotic Communities

Washington University
PI: Herbert Virgin
Title: Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents​

Last Updated September 03, 2014